Figure 1.
Cross indicates the patient' suprasternal notch. (A) 24-hour thyroid radioactive iodine test revealed high uptake (57%; normal reference: 8%-32%) and a diffuse distribution, strengthening the diagnosis of Graves disease. (B) A 24-hour thyroid radioactive iodine test showed high uptake of 36% and a solitary “hot” thyroid nodule in the right lobe, supporting the diagnosis of solitary toxic thyroid nodule. (C) Thyroid ultrasound revealed 1 cystic-solid isoechoic nodule in the right lobe, measuring 1.8 × 1.0 × 0.9 cm, reinforcing the diagnosis of toxic thyroid nodule. (D) A 24-hour thyroid radioactive iodine scan after iodine-131 treatment with 1.11 MBq (30 mCi) showed a homogeneous diffuse thyroid distribution, demonstrating a successful treatment of the solitary toxic thyroid nodule.

Cross indicates the patient' suprasternal notch. (A) 24-hour thyroid radioactive iodine test revealed high uptake (57%; normal reference: 8%-32%) and a diffuse distribution, strengthening the diagnosis of Graves disease. (B) A 24-hour thyroid radioactive iodine test showed high uptake of 36% and a solitary “hot” thyroid nodule in the right lobe, supporting the diagnosis of solitary toxic thyroid nodule. (C) Thyroid ultrasound revealed 1 cystic-solid isoechoic nodule in the right lobe, measuring 1.8 × 1.0 × 0.9 cm, reinforcing the diagnosis of toxic thyroid nodule. (D) A 24-hour thyroid radioactive iodine scan after iodine-131 treatment with 1.11 MBq (30 mCi) showed a homogeneous diffuse thyroid distribution, demonstrating a successful treatment of the solitary toxic thyroid nodule.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close